Step 2/3

Radiation Dose Monitoring

Last updated on December 03, 2021
Company Product
Agfa Healthcare Enterprise Dose Management (powered by DoseMonitor)
Bayer Healthcare LLC Radimetrics Enterprise Platform
Bracco Diagnostics NEXO[DOSE]
Canon Medical Dose Tracking System
Canon Medical Spot Fluoroscopy
Fujifilm Medical Systems U.S.A. Inc. FDX Console (common acquisition workstation for all Fujifilm DR portable and room solutions)
Fujifilm Medical Systems U.S.A. Inc. Aspire AWS Console (common acquisition workstation for all Fujifilm mammography solutions)
GE Healthcare DoseWatch
GE Healthcare DoseWatch Explore
Guerbet LLC Dose&Care
Imalogix Imalogix
Infinitt Healthcare DoseM
Medic Vision Imaging Solutions Ltd. SafeCT
Medic Vision Imaging Solutions Ltd. SafeCT-29
Medic Vision Imaging Solutions Ltd. SafeCT-DR
Medsquare Radiation Dose Monitor (RDM)
Mirion Technologies Instadose+ Dosimeter
Mirion Technologies Instadose Dosimeter
Mirion Technologies Genesis Ultra TLD Dosimeter
MyXrayDose Ltd MyXrayDose
PACSHealth, LLC/PHS Technologies Group LLC DoseMonitor,NexoDose (Bracco), NovaDose (Novarad), Agfa Healthcare Dose Management (Agfa), Radiation Dose Monitor by NTT (Dell)
Philips DoseWise Portal
Qaelum DOSE
Sectra Inc. Sectra DoseTrack

Related Content

Edwin A. Takahashi, M.D., assistant professor of radiology in the division of interventional radiology at the Mayo Clinic College of Medicine in Rochester, Minnesota. Copyright Mayo Clinic College of Medicine
News | AHA
Telehealth is a Valuable Option in Cardiovascular Care, Though Challenges Remain

November 15, 2022 — Telehealth is a proven and valuable option for people with cardiovascular disease, however, there ...

Home November 15, 2022
Home
The "Trending Topics at Sessions 2022" panel of experts featured Manesh R. Patel, MD, FACC, FAHA, Chair of the Committee on AHA 2022 Scientific Sessions, to review highlights and lessons learned from the event.
News | AHA
AHA 2022 Trending Topics: Clinical Trials, Scientific Studies and AI

November 14, 2022 — The American Hospital Association Scientific Sessions 2022, held Nov. 5-7 in Chicago, IL, presented ...

Home November 14, 2022
Home
Findings from the BEST-CLI trial presented at the American Heart Association Scientific Sessions (AHA2022) indicate optimal treatment for patients with limb-threatening ischemia.  
News | AHA
BEST-CLI Clinical Trial Focuses on Optimal Treatment for Limb-Threatening Ischemia

November 10, 2022 ­– Significant findings from the clinical trial, known as “BEST-CLI — Best Endovascular versus Best ...

Home November 10, 2022
Home
Feature | AHA
American Heart Association Honors Distinguished Scientists at AHA22

November 9, 2022 — Seven awardees were honored during the American Heart Association Scientific Sessions (AHA 2022). The ...

Home November 09, 2022
Home
New genomic therapies for cardiovascular disease are reaching the clinical trial stage, according to moderators of a session presented at the American Heart Association Annual Scientific Session (AHA2022).
News | AHA
Progress Reported on Clinical Trials of Genomic Profiling for Cardiovascular Disease at AHA 2022

November 8, 2022 — Genomic-based therapies for cardiovascular disease are emerging fast in research, and could soon be ...

Home November 08, 2022
Home
Robert J. Mentz, M.D., Associate Professor of Medicine, Chief, Heart Failure Section, Associate Program Director, Duke Cardiology Fellowship, Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina, image copyright Robert J. Mentz
News | AHA
TRANSFORM-HF Trial Found No Difference in Effectiveness Between 2 Common Loop Diuretics

November 8, 2022 — After hospital discharge for heart failure, people treated with either loop diuretic medication ...

Home November 08, 2022
Home
Julian D. Gillmore, M.D., Ph.D., Professor, University College London Centre for Amyloidosis, United Kingdom, image copyright University College London Centre for Amyloidosis
News | AHA
Novel Gene-Editing Therapy Shows Promise For Patients With Transthyretin Amyloid Cardiomyopathy

November 8, 2022 — A single IV infusion of NTLA-2001, a novel CRISPR/Cas9-based gene editing therapy, significantly ...

Home November 08, 2022
Home
Clinical studies presented at the American Heart Association 2022 Scientific Sessions event demonstrate compelling diagnostic and health economic value of the Zio suite of products across a range of clinical applications
News | AHA
Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22

November 8, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions ...

Home November 08, 2022
Home
Using coronary computed tomography angiography (CCTA) with HeartFlow’s FFRCT Analysis to evaluate suspected coronary artery disease (CAD) offers more accurate non-invasive diagnosis, fewer unnecessary tests, and higher confidence in identifying patients needing treatment
News | AHA
Late-Breaking Data Demonstrate AHA/ACC Guideline-Directed CCTA ± FFRCT Precision Pathway is Superior to Traditional Testing

November 7, 2022 — HeartFlow, Inc., the leader in revolutionizing precision heartcare, today announced new trial results ...

Home November 07, 2022
Home
A new analysis of iRhythm’s mSToPS trial, presented at the American Heart Association, reveals that Zio XT provided high value from a health economic perspective
News | AHA
New Research Confirms that Zio by iRhythm Provides High Value From a Health Economic Perspective

November 7, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions ...

Home November 07, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now